Cite
HARVARD Citation
Hoffman, J. et al. (2019). Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors. Anti-cancer drugs. 30 (5), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hoffman, J. et al. (2019). Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors. Anti-cancer drugs. 30 (5), p. . [Online].